« Back
Home /
Urotensin II (114-124), human (TFA)

Urotensin II (114-124), human (TFA)

Item no.	HY-P1164A-1mg
Manufacturer	MedChem Express
Amount	1 mg
Quantity options	10 mMx1 mL 10 mg 1 mg 5 mg
Category	Peptides & Proteins Cardiovascular Research Atherosclerosis Peptides
Type	Peptides
Specific against	other
Purity	99.76
Citations	[1]Ames RS, et al. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature. 1999 Sep 16;401(6750):282-6.
Smiles	O=C(N[C@H]1CC2=CNC3=C2C=CC=C3)[C@H](CC4=CC=CC=C4)NC([C@@]([H])(NC([C@@H](NC([C@H]5N(C([C@@H](NC([C@H](CCC(O)=O)N)=O)[C@@H](C)O)=O)CCC5)=O)CC(O)=O)=O)CSSC[C@H](NC([C@@H](NC([C@@]([H])(NC1=O)CCCCN)=O)CC6=CC=C(C=C6)O)=O)C(N[C@@H](C(C)C)C(O)=O)=O)=O.OC(C(F)(F)F)=O
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Shipping Condition	Cool pack
Available
Manufacturer - Type	Peptides
Manufacturer - Applications	COVID-19-immunoregulation
Manufacturer - Targets	Urotensin Receptor
Shipping Temperature	Blue Ice
Storage Conditions	-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Molecular Weight	1502.59
Product Description	Urotensin II (114-124), human TFA, an 11-amino acid residue peptide, is a potent vasoconstrictor and agonist for the orphan receptor GPR14.
Manufacturer - Research Area	Cardiovascular Disease
Solubility	H2O: 100 mg/mL (ultrasonic)
Manufacturer - Pathway	GPCR/G Protein
Clinical information	No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-P1164A-1mg-safety-datasheet.pdf